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Introduction to Workshop on Emerging Issues
in Mergers & Acquisitions and Tribute to
Joseph Flom
SAMUEL THOMPSON, JR.*
In celebration of the new millennium, the University of Miami's
Fourth Annual Institute on Mergers and Acquisitions added a special
Workshop on Emerging Issues in Mergers & Acquisitions and Tribute to
Joseph Flom. The Institute, which was held in February 2000, is co-
chaired by Harvey A. Goldman, of Steel Hector & Davis, Dennis
Hersch, the head of the Mergers and Acquisition Department at Davis
Polk & Wardwell, and myself. We decided that this workshop, which
was added as a bonus third day to our traditional two-day program,
would have an academic orientation, and we enlisted the assistance of
Professor John Coffee, the Adolf A. Berle Professor of Law at the
Columbia University Law School, and one of the Nation's leading
professors of corporate and securities law, in structuring the program.
This special issue of the University of Miami Law Review contains
the papers presented at the workshop. I thank the Law Review, and
particularly Guillermo Levy, the Project Editor, for undertaking this
project.
In structuring the workshop, we wanted both to honor Joseph H.
Flom, a senior partner at Skadden, Arps, Slate, Meagher & Flom, for his
many years of cutting edge practice in the mergers and acquisitions area
and to have him actively participate in the program. Flom, who is
described by Bruce Wasserstein in his book Big Deal as "more than a
distinguished lawyer; ... a business prophet,"1 agreed to participate pro-
vided the program was properly "shaped." He made it clear from the
start that he would only be associated with a substantive program; he
* Professor and Director of Center for the Study of Mergers and Acquisitions, University of
Miami School of Law.
1. BRUCE WASSERSTEIN, BIo DEAL 460 (1998).
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quickly suggested that one of the sessions focus on ethical issues in
mergers and acquisitions; and he indicated that he wanted to participate
in the ethics session.
His suggestion led to a lively panel discussion at the workshop
focusing on a series of hypothetical situations presenting ethical issues
commonly faced by both lawyers and investment bankers active in the
mergers and acquisitions area. The panel, which was moderated by
Louis Kaden of Davis Polk & Wardwell, consisted of the following
leading mergers and acquisitions deal lawyers, litigators, and ethics
experts: Barry S. Alberts, Schiff, Hardin & Waite; Professor Anthony
V. Alfieri, Director, Center for Ethics and Public Service, University of
Miami School of Law; Chancellor William T. Allen, Professor of Law
and Business, New York University, and Wachtell, Lipton, Rosen &
Katz (of counsel); Arthur Fleischer, Jr., Fried, Frank, Harris, Shrive &
Jacobson; Joseph Flom, Skadden, Arps, Slate, Meagher & Flom, LLP;
James Freund, Skadden, Arps, Slate, Meagher & Flom, LLP (of coun-
sel); Edward Labaton, Goodkind Labaton Rudoff & Suchanow LLP;
The Honorable Andrew Moore, Wasserstein & Perella; and Robert H.
Mundheim, Shearman & Sterling (of counsel).
The ethics hypotheticals and the panel discussion are analyzed in an
article in this special issue entitled Ethical Issues Faced by Lawyers and
Investment Bankers in Mergers and Acquisitions: A Problem Approach
and Report of Panel Discussion,2 which is written by Barry S. Alberts
and myself.
Joe Flom also agreed to present at the workshop his views on the
past, present and future of mergers and acquisitions. His outstanding
presentation, which is reflected in his article in this issue entitled Merg-
ers and Acquisitions: The Decade in Review,3 was commented on by the
following preeminent mergers and acquisitions scholars, practitioners,
and investment bankers: Chancellor William T. Allen; Professor Ber-
nard Black, Stanford Law School; Chancellor Williams B. Chandler III,
Delaware Court of Chancery; H. Rodgin Cohen, Sullivan & Cromwell;
Arthur Fleischer Jr.; James Freund; and The Honorable Andrew
Moore. Professor Black's comment, The First International Wave (and
the Fifth and Last U.S. Wave),4 on Flom's presentation is included in
this issue.
2. Barry S. Alberts & Samuel C. Thompson, Jr., Ethical Issues Faced by Lawyers and
Investment Bankers in Mergers and Acquisitions: A Problem Approach and Report of Panel
Discussion, 54 U. MIAMI L. REV. 687 (2000).
3. Joseph Flom, Mergers and Acquisitions: The Decade in Review, 54 U. MIAMI. L. REV.
753 (2000).
4. Bernard Black, The First International Wave (and the Fifth and Last U.S. Wave), 54 U.
MIAMI. L. REV. 799 (2000) [hereinafter Black, International Wave].
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Flom also concurred in Professor Coffee's recommendation that we
invite Professor John Coates of the Harvard Law School to present a
paper focusing on his continuing research into defensive tactics. Fortu-
nately, Professor Coates agreed, and he made a thought-provoking pres-
entation on his views concerning the efficacy of defensive tactics. The
following nationally-recognized mergers and acquisitions academics,
practitioners and jurist commented on Professor Coates's paper: R.
Franklin Balotti, Richards, Layton & Finger; Professor Ronald J. Gilson,
Stanford Law School & Columbia Law School; Professor Jeffrey N.
Gordon, Columbia Law School, Vice Chancellor Jack B. Jacobs, Dela-
ware Court of Chancery; and Professor Roberta Romano, Yale Law
School. Professor Coffee moderated the session.
Professor Coates's presentation is reflected in his article in this
issue entitled Empirical Evidence on Structural Takeover Defenses:
Where Do We Stand?5 This issue also contains the following comments
on Professor Coates's article: Professor Coates is Right. Now Please
Study Stockholder Voting, by Frank Balotti and Travis Laster;6 Poison
Pills and the European Case by Jeffrey Gordon;7 and Comments on
Contestability, by Vice Chancellor Jack Jacobs.8 The final article in this
special workshop issue is Jim Freund's Dinner Tribute to Joe Flom,'
which Freund, a long-time partner of Flom's, delivered at a workshop
dinner honoring Flom.
The balance of this introduction contains brief observations on each
of the articles in this issue.
Coates, Where Do We Stand? In this article, Professor Coates chal-
lenges the findings of both "event studies," which many academics have
relied on in concluding that defensive tactics such as poison pills harm a
target's shareholders, and "premium studies," which many practitioners
have relied on as support for the proposition that poison pills benefit a
target's shareholders. He explains that his "critique shows that, contrary
to the views of either camp, such studies do not provide strong support
either for opposing or supporting takeover defenses." 10
He explains that one of the reasons that the pill adoption or
announcement date, which has been the focus of most event studies is
5. John C. Coates IV, Empirical Evidence on Structural Takeover Defenses: Where Do We
Stand?, 54 U. MIAMI L. REv. 783 (2000) [hereinafter Coates, Where Do We Stand?].
6. R. Franklin Balotti & J. Travis Laster, Professor Coates is Right. Now Please Study
Stockholder Voting, 54 U. MiAMi. L. REV. 819 (2000).
7. Jeffrey N. Gordon, Poison Pills and the European Case, 54 U. MiAMi. L. REV. 839
(2000).
8. Jack Jacobs, Comments on Contestability, 54 U. MIAMI. L. REV. 847 (2000).
9. James Freund, Dinner Tribute to Joe Flom, 54 U. MIAMI. L. REV. 853 (2000).
10. Coates, supra note 5, at 785.
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not important is that virtually "all Delaware firms ... have a 'shadow
pill' in place, written or not, and takeovers of such firms have been
restrained by a set of 'shadow restrictions' .. . on transfer of control to a
hostile bidder."'" He further points out that because of the interaction
among various defenses it may be difficult to study a single defense,
such as the adoption of a pill. In analyzing the premium studies, he
acknowledges that the studies demonstrate that there is a correlation
between pills and deal premiums but he goes on to say that this might be
a classic example of "correlation not proving causation."' 2 He adds that
"[n]one of the [premium] studies offers any explanation of the mecha-
nism by which pills cause higher premiums. '"13
Professor Coates reaches the following policy conclusions: (1)
"Institutional shareholders should be aware of the fact that half the tradi-
tional academic case (at least) against defenses stands on shaky ground
.... ,114 (2) "Boards ... should not be permitted to rely without caveat
on pill premium studies to support a decision to adopt or not adopt a pill
at a given point in time,"' 5 and (3) "Delaware courts . . .should take
some comfort from the fact that they resisted strong academic arguments
...to push them to dramatically repudiate pills and other structural
defenses."16
Balotti and Laster, Coates is Right. In this article, the authors agree
with Professor Coates that "as a practical matter all Delaware corpora-
tions effectively have poison pills ... ."I7 They also question whether it
is possible for event studies to draw "meaningful conclusions about
poison pills because it is not clear that the market, including market
professionals, understands fully the evolving standards that govern the
use of pills and other defensive measures under Delaware law.""8 Sec-
tion Three of this article contains an excellent review of the leading
cases bearing on the use of defensive tactics. This review demonstrates
some of the nuances that permeate this very complex area of the law and
fairly supports the authors' proposition that the market is not informa-
tionally efficient when it comes to assessing the likely outcome of cases
brought by bidders or stockholders that seek to compel a target board of
directors to redeem a defensive measure such as a pill in support of a
11. Id. at 791.
12. Id. at 795.
13. Id.
14. Id. at 797.
15. Id.
16. Id.
17. Balotti & Lester, supra note 6, at 820.
18. Id. at 823.
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takeover attempt. '9 The authors conclude that pills are here to stay and
that since "[s]tockholder voting is the central issue in today's takeover
battles, 2 ° scholars should turn their efforts to studying voting behavior.
Gordon, The European Case. Professor Gordon, who agrees with
Professor Coates's position regarding "shadow pills," reasoned that "as
pills became commonplace so that all firms had one, actual or virtual,
the announcement of pill adoption was merely a signal, often ambigu-
ous, of managerial intentions, rather than an event that changed the tar-
get's vulnerability to takeover."' 21 Professor Gordon also points out that
if the European Union's proposed Thirteenth Directive on Takeover
Bids is adopted along the lines of the UK model, "many troublesome
bidder tactics" 22 that the pill is designed to prevent would not be possi-
ble. He adds that "[i]n particular, [the Thirteenth Directive] would sub-
stitute a mandatory bid for the pill's protection against creeping tender
offers and partial bids."23 Pursuant to the mandatory bid concept, a bid-
der that crosses a particular threshold of stock ownership in a target,
such as thirty percent, is required to extend a bid for all of the target's
shares at the highest price paid for the shares within a certain time
period. Professor Gordon also points out that the Thirteenth Directive
"would prohibit all non-shareholder approved post-bid defensive mea-
sures, which substitute for the pill's appeal as non-destructive. '24 By
non-destructive, he means that pills, unlike defenses such as the sale of a
target's crown jewels, do not destroy the value of a target's assets.
Jacobs, Comments. In his comment, Vice Chancellor Jacobs dis-
cusses the potential impact of "scientific evidence" concerning the eco-
nomic effect of pills on two recent pill cases he presided over in
Delaware: Carmody v. Toll Brothers2 and Mentor Graphics v. Quick-
turn Design Systems, Inc. 26 Toll Brothers dealt with a dead hand pill
and Quickturn addressed a delayed redemption pill, which is a more
limited form of dead hand pill. Both pills had the effect of tying the
hands of any new board that might be seated as a result of a successful
proxy contest or consent solicitation.
In Toll Brothers, he denied a motion to dismiss a challenge to the
pill and in Quickturn, he held that the delayed redemption feature was a
19. Id.
20. Id. at 837.
21. Gordon, supra note 7, at 841.
22. Id. at 842.
23. Id.
24. Id.
25. 723 A.2d 1180 (Del. Ch. 1998).
26. 728 A.2d 25 (Del. Ch. 1998), affd sub. nom., Quickturn Design Systems, Inc. v. Shapiro,
721 A.2d 1281 (Del. Super. Ct. 1998).
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violation of the directors' fiduciary duties. The Delaware Supreme
Court affirmed his decision in Quickturn, but on the grounds that the
delayed redemption feature was fundamentally inconsistent with the
directors' statutory obligation to manage the firm.
Judge Jacobs points out that, in Quickturn, he was required to take
"expert testimony about the likely deterrent effect of the 'no hand'
poison pill and 'delayed redemption' by-law on the public shareholders'
reaction to a hostile takeover bid that offered a modest premium.'"27 He
goes on to say: "How useful it would have been if the cause and effect
relationship, i.e., the deterrent force of the pill, could be determined with
scientific accuracy, and thereby avoid the uncertainties of conventional
fact-finding in a specialized area in which most judges have no personal
expertise."28 He further laments that although Professor Coates "faults
the methodologies used in the prior studies as flawed in their design, he
does not ... propose a methodology that avoids those flaws. '"29
Alberts and Thompson, Ethical Issues. This article focuses on
fourteen ethical issues arising out of a hypothetical fact pattern involving
first, the acquisition of the stock of a closely held corporation; second, a
merger of equals involving two publicly held corporations; and finally, a
hostile tender offer for one of the merging companies. The article
reviews the basic authorities bearing on the particular issues and
attempts to capture the refined and nuanced views expressed by the pan-
elists on the various issues. The hypotheticals demonstrate that there
can be a large overlap between issues involving ethics and issues involv-
ing common law and securities fraud. As the authors conclude, a "mis-
step can lead not only to sanctions for violation of ethical standards but
also to liability for breach of fiduciary or statutory duties."30
Flom, Decade in Review. In this article, Joe Flom not only reviews
the mergers and acquisitions scene during the 1990's, but also makes
insightful observations about each of the past merger waves and sets
forth predictions about the future of mergers and acquisitions. One of
his most interesting observations about the growth of mergers and acqui-
sitions in the 1990's is that while the "growth in the total value of trans-
actions [was] dramatic,"'" there was also a similar dramatic growth in
the market capitalization of traded companies. He also makes the obser-
vation that a "common element of each [of the four previous merger
waves] was that it waxed during periods of high liquidity and waned
27. Jacobs, supra note 8, at 850-851.
28. Id. at 851.
29. Id.
30. Alberts & Thompson, supra note 2, at 752.
31. Flom, supra note 3, at 754.
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with a fall-off in the stock market and illiquidity in the financing mar-
ket."' 32 In predicting the future of mergers and acquisitions, he sets out
numerous factors that "presage ... even stronger growth in mergers and
acquisitions activity. '33
Black, International Wave. Professor Black persuasively argues
that the current merger wave, which is the fifth U.S. merger wave, is the
first international merger wave. He points out that a "growing percent-
age of takeovers are cross-border, major stock markets are increasingly
linked, and U.S. takeover activity is under 45% of the worldwide
total. ' 34 He goes on to say that the "international flavor of the current
merger wave will almost surely be even more prominent in the next
wave, whenever that may be."' 35 And, he argues that when the next
wave arrives "it will no longer maker any sense to talk about American
merger waves at all. Instead, we will come to see the current wave as
the first international merger wave, and its predecessor (the fourth wave)
as the last distinctively American merger wave."36
Freund, Dinner Tribute. Jim Freund's dinner tribute to Joe Flom
shows not only Joe's greatness as a lawyer and his obvious
entrepreneurial spirit, but demonstrates his unswerving commitment to
the ethical practice of the law. In emphasizing this point, Jim says: "It
wasn't accidental that our firm went through all the craziness of the
'80's - smack in the center of the action, with demanding clients and
questionable proposals abounding - without a single mark against our
name. Joe's ethics were absolutely beyond reproach. '37
Thank you Joe Flom for making this workshop truly special.
32. Id. at 776.
33. Id. at 794.
34. Black, supra note 4, at 799.
35. Id. at 801.
36. Id.
37. Freund, supra note 10, at 856.
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